116 related articles for article (PubMed ID: 37455016)
1. Expression of miR-425-5p in Pancreatic Carcinoma and Its Correlation with Tumor Immune Microenvironment.
Jian S; Kong D; Tian J
J Invest Surg; 2023 Dec; 36(1):2216756. PubMed ID: 37455016
[No Abstract] [Full Text] [Related]
2. Pancreatic cancer cell-derived microRNA-155-5p-containing extracellular vesicles promote immune evasion by triggering EHF-dependent activation of Akt/NF-κB signaling pathway.
Wang S; Gao Y
Int Immunopharmacol; 2021 Nov; 100():107990. PubMed ID: 34482266
[TBL] [Abstract][Full Text] [Related]
3. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p.
Zhou WY; Zhang MM; Liu C; Kang Y; Wang JO; Yang XH
J Cell Physiol; 2019 Dec; 234(12):23176-23189. PubMed ID: 31206665
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
[No Abstract] [Full Text] [Related]
6. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
8. DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression
Xu T; Lei T; Li SQ; Mai EH; Ding FH; Niu B
World J Gastroenterol; 2020 Apr; 26(15):1745-1757. PubMed ID: 32351291
[TBL] [Abstract][Full Text] [Related]
9. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer.
Wang C; Li X; Zhang L; Chen Y; Dong R; Zhang J; Zhao J; Guo X; Yang G; Li Y; Gu C; Xi Q; Zhang R
Int Immunopharmacol; 2021 Aug; 97():107822. PubMed ID: 34098485
[TBL] [Abstract][Full Text] [Related]
10. LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Pancreatology; 2020 Sep; 20(6):1139-1148. PubMed ID: 32732173
[TBL] [Abstract][Full Text] [Related]
11. circSFMBT1 promotes pancreatic cancer growth and metastasis via targeting miR-330-5p/PAK1 axis.
Xu S; Lei SL; Liu KJ; Yi SG; Yang ZL; Yao HL
Cancer Gene Ther; 2021 Apr; 28(3-4):234-249. PubMed ID: 32855541
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA Differentiation Antagonizing Nonprotein Coding RNA (DANCR) Promotes Proliferation and Invasion of Pancreatic Cancer by Sponging miR-214-5p to Regulate E2F2 Expression.
Yao Z; Chen Q; Ni Z; Zhou L; Wang Y; Yang Y; Huang H
Med Sci Monit; 2019 Jun; 25():4544-4552. PubMed ID: 31213582
[TBL] [Abstract][Full Text] [Related]
13. Role of miR-214-5p in the migration and invasion of pancreatic cancer cells.
Cao TH; Ling X; Chen C; Tang W; Hu DM; Yin GJ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7214-7221. PubMed ID: 30468464
[TBL] [Abstract][Full Text] [Related]
14. Hsa_circ_0046523 Mediates an Immunosuppressive Tumor Microenvironment by Regulating MiR-148a-3p/PD-L1 Axis in Pancreatic Cancer.
Fu X; Sun G; Tu S; Fang K; Xiong Y; Tu Y; Zha M; Xiao T; Xiao W
Front Oncol; 2022; 12():877376. PubMed ID: 35712476
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA CASC9 promotes pancreatic cancer progression by acting as a ceRNA of miR-497-5p to upregulate expression of CCND1.
Zhou J; Song G; Su M; Zhang H; Yang T; Song Z
Environ Toxicol; 2023 Jun; 38(6):1251-1264. PubMed ID: 36947456
[TBL] [Abstract][Full Text] [Related]
16. Downregulated miR-524-5p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis.
Chen L; Wang G; Qiao X; Wang X; Liu J; Niu X; Zhong M
Med Sci Monit; 2020 Jan; 26():e921863. PubMed ID: 31990904
[TBL] [Abstract][Full Text] [Related]
17. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
[TBL] [Abstract][Full Text] [Related]
18. CERS6-AS1 promotes cell proliferation and represses cell apoptosis in pancreatic cancer via miR-195-5p/WIPI2 axis.
Gao KF; Zhao YF; Liao WJ; Xu GL; Zhang JD
Kaohsiung J Med Sci; 2022 Jun; 38(6):542-553. PubMed ID: 35199935
[TBL] [Abstract][Full Text] [Related]
19. Yin Yang 1-induced activation of LINC01133 facilitates the progression of pancreatic cancer by sponging miR-199b-5p to upregulate myelin regulatory factor expression.
Yang X; Wang L; Zhou F; Ye S; Sun Q
Bioengineered; 2022 May; 13(5):13352-13365. PubMed ID: 35659199
[TBL] [Abstract][Full Text] [Related]
20. [Correlations between miRNAs and TGF-β1 in tumor microenvironment of esophageal squamous cell cancer].
Zhu L; Jin L; Jiang R; Wang Q; Jiang J; Mao C; Chen D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 May; 29(5):524-8. PubMed ID: 23643275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
